ORIC PHARMACEUTICALS INC (ORIC) Institutional Ownership Changes & 13F Activity
ORIC PHARMACEUTICALS INC (ORIC). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q1 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Price T Rowe Associates Inc, Venrock Adviser, Llc, Braidwell Lp, Woodline Partners Lp, and Orbimed Advisors Llc.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Mirae Asset Global Investments Co., Ltd. | Buy | +503 | +10.6% | 5,235 | $66.33K | Q1 2026 | Aug 12, 2026 |
| Algert Global Llc | Buy | +95,840 | +236.6% | 136,350 | $1.73M | Q1 2026 | Aug 11, 2026 |
| Wells Fargo & Company/Mn | Sell | -43,424 | -52.6% | 39,108 | $495.50K | Q1 2026 | Jul 08, 2026 |
| Bank Of America Corp | Buy | +535,649 | +105.5% | 1,043,159 | $13.22M | Q1 2026 | May 18, 2026 |
| California State Teachers Retirement System | Buy | +14,410 | +42.4% | 48,369 | $612.84K | Q1 2026 | May 18, 2026 |
| Price T Rowe Associates Inc | Buy | +2,092,661 | +63.5% | 5,387,783 | $68.26M | Q1 2026 | May 15, 2026 |
| Venrock Adviser, Llc | Sell | -1,356,465 | -23.9% | 4,319,765 | $54.73M | Q1 2026 | May 15, 2026 |
| Braidwell Lp | Buy | +1,128,040 | — | 1,128,040 | $14.29M | Q1 2026 | May 15, 2026 |
| Woodline Partners Lp | Buy | +1,000,981 | +406.0% | 1,247,515 | $15.81M | Q1 2026 | May 15, 2026 |
| Orbimed Advisors Llc | Sell | -947,827 | -26.0% | 2,693,929 | $34.13M | Q1 2026 | May 15, 2026 |
| Viking Global Investors | Sell | -748,158 | -11.4% | 5,824,533 | $73.80M | Q1 2026 | May 15, 2026 |
| Barclays Plc | Sell | -706,106 | -98.3% | 12,429 | $157.47K | Q1 2026 | May 15, 2026 |
| Paradigm Biocapital Advisors Lp | Sell | -700,000 | -29.2% | 1,701,217 | $21.55M | Q1 2026 | May 15, 2026 |
| Sofinnova Investments, Inc. | Buy | +679,578 | — | 679,578 | $8.61M | Q1 2026 | May 15, 2026 |
| State Street Corp | Sell | -556,201 | -13.1% | 3,702,196 | $46.91M | Q1 2026 | May 15, 2026 |
| Logos Global Management Lp | Buy | +500,000 | +111.1% | 950,000 | $12.04M | Q1 2026 | May 15, 2026 |
| Morgan Stanley | Buy | +488,450 | +40.9% | 1,682,523 | $21.32M | Q1 2026 | May 15, 2026 |
| Sphera Funds Management Ltd. | Sell | -466,750 | -46.5% | 537,628 | $6.81M | Q1 2026 | May 15, 2026 |
| Goldman Sachs Group Inc | Sell | -463,573 | -23.9% | 1,475,712 | $18.70M | Q1 2026 | May 15, 2026 |
| Balyasny Asset Management L.P. | Sell | -426,424 | -44.9% | 523,790 | $6.64M | Q1 2026 | May 15, 2026 |
| Qube Research & Technologies Ltd | Sell | -345,938 | -28.7% | 859,491 | $10.89M | Q1 2026 | May 15, 2026 |
| Vivo Capital, Llc | Sell | -269,598 | -12.7% | 1,848,786 | $23.42M | Q1 2026 | May 15, 2026 |
| Adage Capital Partners Gp, L.L.C. | Sell | -204,685 | -37.3% | 344,315 | $4.36M | Q1 2026 | May 15, 2026 |
| Integral Health Asset Management, Llc | Buy | +200,000 | +16.7% | 1,400,000 | $17.74M | Q1 2026 | May 15, 2026 |
| Boxer Capital Management, Llc | Buy | +176,500 | — | 176,500 | $2.24M | Q1 2026 | May 15, 2026 |
| Boothbay Fund Management, Llc | Sell | -156,653 | -71.7% | 61,957 | $785.00K | Q1 2026 | May 15, 2026 |
| Alyeska Investment Group, L.P. | Buy | +137,489 | — | 137,489 | $1.74M | Q1 2026 | May 15, 2026 |
| Arrowmark Colorado Holdings Llc | Sell | -103,252 | -9.7% | 960,517 | $12.17M | Q1 2026 | May 15, 2026 |
| Abu Dhabi Investment Council Co P.J.S.C | Buy | +89,441 | — | 89,441 | $1.13M | Q1 2026 | May 15, 2026 |
| Geode Capital Management, Llc | Buy | +88,107 | +5.0% | 1,838,801 | $23.30M | Q1 2026 | May 15, 2026 |
Frequently asked questions about ORIC activity
Which institutional owners are buying ORIC?
Institutional owners buying ORIC include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in ORIC activity?
"Buy" means an investor increased their reported position in ORIC compared to the prior reporting period. This reflects growing exposure to ORIC PHARMACEUTICALS INC (ORIC) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in ORIC increasing?
Institutional interest in ORIC can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related ORIC Institutional Insights
- ORIC Overview
- ORIC 13F Institutional Holders
- ORIC Superinvestors
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- ORIC Insider Trading & SEC Form 4 Activity
- ORIC Articles
- Top Institutional Investor Stock Rankings